Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Diabetes

  Free Subscription


01.03.2021

4 Am Heart J
1 Am J Epidemiol
1 Am J Med
1 Biochem Biophys Res Commun
1 Br J Ophthalmol
1 Circulation
5 Diabet Med
4 Diabetes
11 Diabetes Care
3 Diabetes Obes Metab
3 Diabetologia
2 Eur J Endocrinol
6 Hypertension
1 J Am Soc Nephrol
3 J Biol Chem
8 J Clin Endocrinol Metab
2 J Clin Invest
7 J Diabetes Complications
2 J Pediatr
1 JAMA
5 Metabolism
3 N Engl J Med
1 PLoS Med
6 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. BERGER JH, Chen F, Faerber JA, O'Byrne ML, et al
    Adherence with lipid screening guidelines in standard- and high-risk children and adolescents.
    Am Heart J. 2021;232:39-46.
    PubMed         Abstract available

  2. SALAH HM, Al'Aref SJ, Khan MS, Al-Hawwas M, et al
    Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials.
    Am Heart J. 2020;232:10-22.
    PubMed         Abstract available

  3. COX ZL, Collins SP, Aaron M, Hernandez GA, et al
    Efficacy and Safety of Dapagliflozin in Acute Heart Failure: Rationale and Design of the DICTATE-AHF trial.
    Am Heart J. 2020 Oct 31. pii: S0002-8703(20)30357.
    PubMed         Abstract available

  4. HAMO CE, Fonarow GC, Greene SJ, Vaduganathan M, et al
    Temporal Trends in Risk Profiles Among Patients Hospitalized for Heart Failure.
    Am Heart J. 2020 Nov 29. pii: S0002-8703(20)30397.
    PubMed         Abstract available


    Am J Epidemiol

  5. KOSHIOL J, Van De Wyngard V, McGee EE, Cook P, et al
    The Chile Biliary Longitudinal Study: A Gallstone Cohort.
    Am J Epidemiol. 2021;190:196-206.
    PubMed         Abstract available


    Am J Med

  6. RIPPE JM
    The Silent Epidemic.
    Am J Med. 2021;134:164-165.
    PubMed        


    Biochem Biophys Res Commun

  7. ZHOU B, Dong C, Zhao B, Su X, et al
    (EX-4)2-Fc, an effective long-acting GLP-1 receptor agonist, reduces obesity-related inflammation by inhibiting leptin expression.
    Biochem Biophys Res Commun. 2020;529:562-568.
    PubMed         Abstract available


    Br J Ophthalmol

  8. SABANAYAGAM C, Sultana R, Banu R, Rim T, et al
    Association between body mass index and diabetic retinopathy in Asians: the Asian Eye Epidemiology Consortium (AEEC) study.
    Br J Ophthalmol. 2021 Feb 23. pii: bjophthalmol-2020-318208.
    PubMed         Abstract available


    Circulation


  9. Correction to: Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA Therapy.
    Circulation. 2021;143:e744.
    PubMed        


    Diabet Med

  10. LUK AOY, Ng SSS, Holt RI
    Impact of diabetes on COVID-19 and other infection: report from the 22(nd) Hong Kong Diabetes and Cardiovascular Risk Factors - East Meets West Symposium.
    Diabet Med. 2021 Feb 22:e14547. doi: 10.1111/dme.14547.
    PubMed         Abstract available

  11. KUMBHOJKAR A, Saraff V, Nightingale P, Hogler W, et al
    Glycated haemoglobin as a screening test for abnormal glucose homeostasis in childhood obesity.
    Diabet Med. 2020;37:356-361.
    PubMed         Abstract available

  12. STANTON-FAY SH, Hamilton K, Chadwick PM, Lorencatto F, et al
    The DAFNEplus programme for sustained type 1 diabetes self-management: Intervention development using the Behaviour Change Wheel.
    Diabet Med. 2021 Feb 22:e14548. doi: 10.1111/dme.14548.
    PubMed         Abstract available

  13. REIDY C, Foster C, Rogers A
    A novel exploration of the support needs of people initiating insulin pump therapy using a social network approach: a longitudinal mixed-methods study.
    Diabet Med. 2020;37:298-310.
    PubMed         Abstract available

  14. DANKNER R, Roth J
    More recent, better designed studies have weakened links between antidiabetes medications and cancer risk.
    Diabet Med. 2020;37:194-202.
    PubMed         Abstract available


    Diabetes

  15. HERDER C, Maalmi H, Strassburger K, Zaharia OP, et al
    Differences in Biomarkers of Inflammation Between Novel Subgroups of Recent-Onset Diabetes.
    Diabetes. 2021 Feb 19. pii: db20-1054. doi: 10.2337/db20-1054.
    PubMed         Abstract available

  16. QU H, Miao T, Wang Y, Tan L, et al
    Dedicator of Cytokinesis 5 Regulates Keratinocyte Function and Promotes Diabetic Wound Healing.
    Diabetes. 2021 Feb 24. pii: db20-1008. doi: 10.2337/db20-1008.
    PubMed         Abstract available

  17. LIN A, Mack JA, Bruggeman B, Jacobsen LM, et al
    Low-dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report.
    Diabetes. 2021 Feb 25. pii: db20-1103. doi: 10.2337/db20-1103.
    PubMed         Abstract available

  18. HALLER MJ, Jacobsen LM, Posgai AL, Schatz DA, et al
    How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?
    Diabetes. 2021 Feb 25. pii: dbi20-0045. doi: 10.2337/dbi20-0045.
    PubMed         Abstract available


    Diabetes Care

  19. SOLIS-HERRERA C, Daniele G, Alatrach M, Agyin C, et al
    Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion.
    Diabetes Care. 2020;43:1065-1069.
    PubMed         Abstract available

  20. HUANG R, Yin S, Ye Y, Chen N, et al
    Circulating Retinol-Binding Protein 4 Is Inversely Associated With Pancreatic beta-Cell Function Across the Spectrum of Glycemia.
    Diabetes Care. 2020;43:1258-1265.
    PubMed         Abstract available

  21. PASTERNAK B, Wintzell V, Eliasson B, Svensson AM, et al
    Use of Glucagon-Like Peptide 1 Receptor Agonists and Risk of Serious Renal Events: Scandinavian Cohort Study.
    Diabetes Care. 2020;43:1326-1335.
    PubMed         Abstract available

  22. KUO S, Ye W, de Groot M, Saha C, et al
    Cost-effectiveness of Community-Based Depression Interventions for Rural and Urban Adults With Type 2 Diabetes: Projections From Program ACTIVE (Adults Coming Together to Increase Vital Exercise) II.
    Diabetes Care. 2021 Feb 19. pii: dc20-1639. doi: 10.2337/dc20-1639.
    PubMed         Abstract available

  23. FUKUDA T, Bouchi R, Takeuchi T, Amo-Shiinoki K, et al
    Importance of Intestinal Environment and Cellular Plasticity of Islets in the Development of Postpancreatectomy Diabetes.
    Diabetes Care. 2021 Feb 24. pii: dc20-0864. doi: 10.2337/dc20-0864.
    PubMed         Abstract available

  24. ZHENG X, Yang D, Luo S, Yan J, et al
    Association of Implementation of a Comprehensive Preconception-to-Pregnancy Management Plan With Pregnancy Outcomes Among Chinese Pregnant Women With Type 1 Diabetes: The CARNATION Study.
    Diabetes Care. 2021 Feb 24. pii: dc20-2692. doi: 10.2337/dc20-2692.
    PubMed         Abstract available

  25. KLEIN KR, Freeman JLR, Dunn I, Dvergsten C, et al
    The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 Diabetes.
    Diabetes Care. 2021 Feb 23. pii: dc20-2684. doi: 10.2337/dc20-2684.
    PubMed         Abstract available

  26. HERRING RA, Shojaee-Moradie F, Garesse R, Stevenage M, et al
    Response to Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128-2136.
    Diabetes Care. 2021;44:e61.
    PubMed        

  27. BOLLI GB, Porcellati F, Lucidi P, Fanelli CG, et al
    Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128-2136.
    Diabetes Care. 2021;44:e59-e60.
    PubMed        

  28. DE GROOT M
    50 Years of Behavioral Science in Diabetes: A 2020 Vision of the Future.
    Diabetes Care. 2021;44:633-640.
    PubMed         Abstract available

  29. FERRANNINI E, Rosenstock J
    Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye?
    Diabetes Care. 2021;44:641-646.
    PubMed         Abstract available


    Diabetes Obes Metab

  30. LI FR, Yang HL, Zhou R, Zheng JZ, et al
    Diabetes Duration and Glycemic Control as Predictors of Cardiovascular Disease and Mortality.
    Diabetes Obes Metab. 2021 Feb 23. doi: 10.1111/dom.14348.
    PubMed         Abstract available

  31. OLDGREN J, Laurila S, Akerblom A, Latva-Rasku A, et al
    Effects of 6 weeks treatment with dapagliflozin, a sodium-glucose co-transporter 2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: a randomized placebo-controlled exploratory study.
    Diabetes Obes Metab. 2021 Feb 24. doi: 10.1111/dom.14363.
    PubMed         Abstract available

  32. ARAKI E, Mathieu C, Shiraiwa T, Maeda H, et al
    Long-term (52-week) efficacy and safety of dapagliflozin as adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT-2 study.
    Diabetes Obes Metab. 2021 Feb 23. doi: 10.1111/dom.14362.
    PubMed         Abstract available


    Diabetologia

  33. CHEN Y, Zhang P, Wang J, Gong Q, et al
    Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Preventi
    Diabetologia. 2021 Feb 19. pii: 10.1007/s00125-021-05401.
    PubMed         Abstract available

  34. O'DONOGHUE ML, Kato ET, Mosenzon O, Murphy SA, et al
    The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus.
    Diabetologia. 2021 Feb 20. pii: 10.1007/s00125-021-05399.
    PubMed         Abstract available

  35. HOHN A, Jeyam A, Caparrotta TM, McGurnaghan SJ, et al
    The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes.
    Diabetologia. 2021 Feb 19. pii: 10.1007/s00125-021-05394.
    PubMed         Abstract available


    Eur J Endocrinol

  36. FAN HM, Mitchell AL, Williamson C
    ENDOCRINOLOGY IN PREGNANCY: Metabolic impact of bile acids in gestation.
    Eur J Endocrinol. 2021;184:R69-R83.
    PubMed         Abstract available

  37. BEHANOVA M, Haschka J, Zwerina J, Wascher TC, et al
    The doubled burden of diabetic bone disease: hip fracture and post-hip fracture mortality.
    Eur J Endocrinol. 2021 Feb 1. pii: EJE-20-1155.R1. doi: 10.1530/EJE-20-1155.
    PubMed         Abstract available


    Hypertension

  38. ZANETTI D, Bergman H, Burgess S, Assimes TL, et al
    Urinary Albumin, Sodium, and Potassium and Cardiovascular Outcomes in the UK Biobank: Observational and Mendelian Randomization Analyses.
    Hypertension. 2020 Feb 3:HYPERTENSIONAHA11914028.
    PubMed         Abstract available

  39. ASSIBEY-MENSAH V, Glantz JC, Hopke PK, Jusko TA, et al
    Wintertime Wood Smoke, Traffic Particle Pollution, and Preeclampsia.
    Hypertension. 2020;75:851-858.
    PubMed         Abstract available

  40. AGARWAL R, Song RJ, Vasan RS, Xanthakis V, et al
    Left Ventricular Mass and Incident Chronic Kidney Disease.
    Hypertension. 2020;75:702-706.
    PubMed         Abstract available

  41. AUGER N, Potter BJ, He S, Healy-Profitos J, et al
    Maternal Cardiovascular Disease 3 Decades After Preterm Birth: Longitudinal Cohort Study of Pregnancy Vascular Disorders.
    Hypertension. 2020 Feb 3:HYPERTENSIONAHA11914221.
    PubMed         Abstract available

  42. WU DD, Gao L, Huang O, Ullah K, et al
    Increased Adverse Pregnancy Outcomes Associated With Stage 1 Hypertension in a Low-Risk Cohort: Evidence From 47 874 Cases.
    Hypertension. 2020 Feb 3:HYPERTENSIONAHA11914252.
    PubMed         Abstract available

  43. JOSEPH G, Marott JL, Biering-Sorensen T, Johansen MN, et al
    Level of Physical Activity, Left Ventricular Mass, Hypertension, and Prognosis.
    Hypertension. 2019 Dec 30:HYPERTENSIONAHA11914287.
    PubMed         Abstract available


    J Am Soc Nephrol

  44. FERGUSON R, Leatherman S, Fiore M, Minnings K, et al
    Prevalence and Risk Factors for CKD in the General Population of Southwestern Nicaragua.
    J Am Soc Nephrol. 2020;31:1585-1593.
    PubMed         Abstract available


    J Biol Chem

  45. SHAH AM, Wondisford FE
    Tracking the carbons supplying gluconeogenesis.
    J Biol Chem. 2020;295:14419-14429.
    PubMed         Abstract available

  46. PERRY RJ, Shulman GI
    Sodium-glucose cotransporter-2 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risks.
    J Biol Chem. 2020;295:14379-14390.
    PubMed         Abstract available

  47. MAITY S, Das F, Kasinath BS, Ghosh-Choudhury N, et al
    TGFbeta acts through PDGFRbeta to activate mTORC1 via the Akt/PRAS40 axis and causes glomerular mesangial cell hypertrophy and matrix protein expression.
    J Biol Chem. 2020;295:14262-14278.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  48. INZUCCHI SE, Khunti K, Fitchett DH, Wanner C, et al
    Cardiovascular (CV) Benefit of Empagliflozin Across the Spectrum of CV Risk Factor Control in the EMPA-REG OUTCOME Trial.
    J Clin Endocrinol Metab. 2020 Jun 2. pii: 5850548. doi: 10.1210.
    PubMed         Abstract available

  49. POLLANEN PM, Ryhanen SJ, Toppari J, Ilonen J, et al
    Dynamics of Islet Autoantibodies During Prospective Follow-Up from Birth up to 15 Years of Age.
    J Clin Endocrinol Metab. 2020 Sep 3. pii: 5901133. doi: 10.1210.
    PubMed         Abstract available

  50. XU X, Zhang T, Mokou M, Li L, et al
    Follistatin-like 1 as a Novel Adipomyokine Related to Insulin Resistance and Physical Activity.
    J Clin Endocrinol Metab. 2020;105.
    PubMed         Abstract available

  51. LU YK, Chu X, Wang S, Sun Y, et al
    Identification of circulating hsa_circ_0063425 and hsa_circ_0056891 as novel biomarkers for detection of type 2 diabetes.
    J Clin Endocrinol Metab. 2021 Feb 20. pii: 6145112. doi: 10.1210.
    PubMed         Abstract available

  52. COSSEN K, Muir A
    Response to Letter to the Editor from Petra Pllnen, et al: "Birth cohorts in type 1 diabetes: preparing for the payoff".
    J Clin Endocrinol Metab. 2021 Feb 24. pii: 6149070. doi: 10.1210.
    PubMed        

  53. POLLANEN PM, Knip M
    Letter to the Editor from Petra Pollanen, et al: "Birth Cohorts in Type 1 Diabetes: Preparing for the Payoff".
    J Clin Endocrinol Metab. 2021 Feb 24. pii: 6149071. doi: 10.1210.
    PubMed        

  54. BIASSONI R, Di Marco E, Squillario M, Barla A, et al
    Gut Microbiota in T1DM-Onset Pediatric Patients: Machine-Learning Algorithms to Classify Microorganisms as Disease Linked.
    J Clin Endocrinol Metab. 2020;105.
    PubMed         Abstract available

  55. MOLLER N
    Ketone Body, 3-Hydroxybutyrate: Minor Metabolite - Major Medical Manifestations.
    J Clin Endocrinol Metab. 2020;105.
    PubMed         Abstract available


    J Clin Invest

  56. NEILL US
    A conversation with C. Ronald Kahn.
    J Clin Invest. 2020;130:5029-5030.
    PubMed        

  57. PRABHAKAR NR, Peng YJ, Nanduri J
    Hypoxia-inducible factors and obstructive sleep apnea.
    J Clin Invest. 2020;130:5042-5051.
    PubMed         Abstract available


    J Diabetes Complications

  58. GEDEBJERG A, Thomsen RW, Kjaergaard AD, Steffensen R, et al
    Mannose-binding lectin and risk of infections in type 2 diabetes: A Danish cohort study.
    J Diabetes Complications. 2021 Jan 26:107873.
    PubMed         Abstract available

  59. IDA S, Kaneko R, Imataka K, Fujiwara R, et al
    Are diabetes-related factors associated with the social roles of elderly patients with diabetes?
    J Diabetes Complications. 2021;35:107759.
    PubMed         Abstract available

  60. VENDRAME F, Calhoun P, Bocchino LE, Pratley RE, et al
    Impact of bariatric surgery and weight loss medications in adults with type 1 diabetes in the T1D Exchange Clinic Registry.
    J Diabetes Complications. 2021 Feb 9:107884. doi: 10.1016/j.jdiacomp.2021.107884
    PubMed         Abstract available

  61. SHIN KJ, Kang JW, Sung KH, Park SH, et al
    Quantitative gait and postural analyses in patients with diabetic polyneuropathy.
    J Diabetes Complications. 2021 Jan 17:107857.
    PubMed         Abstract available

  62. LEE HW, Lee JS, Kim BK, Park JY, et al
    Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2years.
    J Diabetes Complications. 2021;35:107747.
    PubMed         Abstract available

  63. HUANG B, Huang Z, Tan J, Xu H, et al
    The mediating and interacting role of physical activity and sedentary behavior between diabetes and depression in people with obesity in United States.
    J Diabetes Complications. 2021;35:107764.
    PubMed         Abstract available

  64. DIAS GD, Cartolano FC, Freitas MCP, Santa-Helena E, et al
    Adiponectin predicts the antioxidant capacity and size of high-density lipoprotein (HDL) in individuals with diabetes mellitus.
    J Diabetes Complications. 2021 Jan 22:107856.
    PubMed         Abstract available


    J Pediatr

  65. NI J, Khosla C, Maahs DM
    50 Years Ago in TheJournalofPediatrics: Association of Type 1 Diabetes Mellitus and Celiac Disease: Then and Now.
    J Pediatr. 2021;230:70.
    PubMed        

  66. NICHOLAS BENG HUI N
    QTc in Diabetic Ketoacidosis.
    J Pediatr. 2021 Feb 19. pii: S0022-3476(21)00177.
    PubMed        


    JAMA

  67. SLOMSKI A
    Finerenone for Patients With CKD and Type 2 Diabetes.
    JAMA. 2021;325:713.
    PubMed        


    Metabolism

  68. POLYZOS SA, Mantzoros CS
    Diabetes mellitus: 100 years since the discovery of insulin.
    Metabolism. 2021 Feb 18:154737. doi: 10.1016/j.metabol.2021.154737.
    PubMed         Abstract available

  69. WANG H, Huang X, Xu P, Liu X, et al
    Apolipoprotein C3 aggravates diabetic nephropathy in type 1 diabetes by activating the renal TLR2/NF-kappaB pathway.
    Metabolism. 2021 Feb 24:154740. doi: 10.1016/j.metabol.2021.154740.
    PubMed         Abstract available

  70. AHN J, Koh J, Kim D, Kim G, et al
    Mean and visit-to-visit variability of glycemia and left ventricular diastolic dysfunction: A longitudinal analysis of 3025 adults with serial echocardiography.
    Metabolism. 2021;116:154451.
    PubMed         Abstract available

  71. LI X, Jiang Y, Sun X, Wu Y, et al
    METTL3 is required for maintaining beta-cell function.
    Metabolism. 2021;116:154702.
    PubMed         Abstract available

  72. STEVANOVIC-SILVA J, Beleza J, Coxito P, Pereira S, et al
    Maternal high-fat high-sucrose diet and gestational exercise modulate hepatic fat accumulation and liver mitochondrial respiratory capacity in mothers and male offspring.
    Metabolism. 2021;116:154704.
    PubMed         Abstract available


    N Engl J Med

  73. SUZUKI Y, Zhao T, Tsubokura M
    Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment.
    N Engl J Med. 2021;384:e26.
    PubMed        

  74. SHAH VN
    Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment.
    N Engl J Med. 2021;384:e26.
    PubMed        

  75. ROSENSTOCK J, Hansen MV, Goldenberg R
    Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment. Reply.
    N Engl J Med. 2021;384:e26.
    PubMed        


    PLoS Med

  76. MANOUSAKI D, Harroud A, Mitchell RE, Ross S, et al
    Vitamin D levels and risk of type 1 diabetes: A Mendelian randomization study.
    PLoS Med. 2021;18:e1003536.
    PubMed         Abstract available


    PLoS One

  77. NAKADE Y, Kitano R, Sakamoto K, Kimoto S, et al
    Characteristics of bile acid composition in high fat diet-induced nonalcoholic fatty liver disease in obese diabetic rats.
    PLoS One. 2021;16:e0247303.
    PubMed         Abstract available

  78. AJABNOOR GMA, Bahijri S, Alamoudi AA, Al Raddadi R, et al
    The association between hypertension and other cardiovascular risk factors among non-diabetic Saudis adults-A cross sectional study.
    PLoS One. 2021;16:e0246568.
    PubMed         Abstract available

  79. MOHAMMAD H, Abutaleb NS, Dieterly AM, Lyle LT, et al
    Evaluation of ebselen in resolving a methicillin-resistant Staphylococcus aureus infection of pressure ulcers in obese and diabetic mice.
    PLoS One. 2021;16:e0247508.
    PubMed         Abstract available

  80. FATHI M, Vakili K, Sayehmiri F, Mohamadkhani A, et al
    The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study.
    PLoS One. 2021;16:e0246190.
    PubMed         Abstract available

  81. SCHONFELD D, Arias S, Bossio JC, Fernandez H, et al
    Clinical presentation and outcomes of the first patients with COVID-19 in Argentina: Results of 207079 cases from a national database.
    PLoS One. 2021;16:e0246793.
    PubMed         Abstract available

  82. OLUMA A, Abadiga M, Mosisa G, Etafa W, et al
    Magnitude and predictors of poor glycemic control among patients with diabetes attending public hospitals of Western Ethiopia.
    PLoS One. 2021;16:e0247634.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  83. WANG MY, Dean ED, Quittner-Strom E, Zhu Y, et al
    Glucagon blockade restores functional beta-cell mass in type 1 diabetic mice and enhances function of human islets.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: